Educational Blogs

Why Sleep Issues Often Overlap With Stress and Anxiety
Sleep

Why Sleep Issues Often Overlap With Stress and Anxiety

Sleep concerns rarely exist in isolation. Patients who report difficulty falling asleep, staying asleep, or feeling rested often describe overlapping experiences with stress, anxiety, or changes in...

Read more
Medication Review and Sleep: What Clinicians Look For
Sleep

Medication Review and Sleep: What Clinicians Look For

Medication review is a foundational part of evaluating sleep concerns. Many substances—prescription medications, over-the-counter products, supplements, and daily substances—can influence sleep pat...

Read more
How Clinicians Evaluate Sleep Concerns in Telehealth Care
Sleep

How Clinicians Evaluate Sleep Concerns in Telehealth Care

Sleep concerns are among the most common reasons patients seek clinical guidance, yet they are also some of the most misunderstood. Difficulty falling asleep, staying asleep, or feeling rested can ...

Read more
Struggling With Sleep? How Clinical Cannabinoid Care May Support Rest and Recovery.
Sleep

Struggling With Sleep? How Clinical Cannabinoid Care May Support Rest and Recovery.

Sleep issues affect nearly one-third of adults, impacting mood, focus, immune health, and overall quality of life. From difficulty falling asleep to frequent nighttime awakenings, chronic sleep dis...

Read more
Important safety information

Prescription cannabinoid therapies require clinical oversight.

Common side effects

Prescription cannabinoid therapies may cause drowsiness, fatigue, changes in appetite, diarrhea, and dry mouth. Effects vary by patient, dose, and formulation.

Drug‑interaction risk

CBD can affect how the body metabolizes other medications through cytochrome P450 liver enzymes, which may alter the effectiveness or safety of prescriptions including blood thinners, anti‑seizure medications, and some antidepressants. Disclose all current medications and supplements to your clinician during evaluation.

Liver‑enzyme monitoring

Elevated liver enzymes have been observed in clinical research on CBD, particularly at higher doses. Your clinician may recommend liver‑function testing before or during your protocol. Patients with existing liver conditions require additional review.

Not FDA‑approved

Compounded cannabinoid formulations are prepared under FDA 503A regulations for individual patients. They are not FDA‑approved drugs and have not been evaluated by the FDA for safety, efficacy, or quality in the same way as commercial pharmaceuticals. Compounded medications are prescribed when a clinician determines a commercially available product is not appropriate for a specific patient.

This information is provided for educational purposes and does not replace clinical advice. Speak with a licensed clinician before beginning any cannabinoid protocol. Telehealth currently available in Colorado only. Individual results vary. Prescription decisions are made solely by a licensed clinician and are never automatic.